OR5AH1P

Across TCGA pan-cancer cohorts, OR5AH1P RNA is linked to patient survival in 11 of 34 cancer types, making it the most broadly survival-associated OR5AH1P data layer.

The strongest signal is observed in stomach adenocarcinoma (STAD), where higher OR5AH1P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated OR5AH1P expression acts as an unfavorable survival marker.

STAD, ESCA, and PAAD are the cancer types where OR5AH1P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
STAD	OS	Tertile	IV	0.146	0.520	.012	36	view →
ESCA	DFS	Tertile	All	0.243	0.771	.020	18	view →
PAAD	DFS	Tertile	III,IV	0.118	0.734	.014	18	view →
LAML	DFS	Tertile	All	0.213	0.499	.043	18	view →
LIHC	OS	Tertile	III,IV	0.263	0.579	.026	18	view →
SKCM	DFS	Tertile	All	0.403	0.647	.018	15	view →
KIRC	DFS	Tertile	IV	0.231	0.549	.015	12	view →
COAD	DFS	Tertile	All	0.298	0.697	.014	9	view →
READ	DFS	Tertile	IV	0.095	0.697	.014	9	view →
LGG	DFS	Tertile	All	0.262	0.484	.012	4	view →
THYM	DFS	Tertile	II,III,IV	0.635	0.880	.049	3	view →

Pink = unfavorable, green = favorable. Showing the 11 strongest of 11 lineages.

OR5AH1P–STAD (OS)

Open the STAD breakdown →